| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |